This is the most critical time in history for the global drug discovery and development community to come together. Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly as new viral variants occur that could still evade vaccines.
Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.
Join us at the congress to get up to speed and help accelerate your antiviral research from bench to patient.
With hundreds of potential customers in attendance there will be opportunities to meet & network with contacts who are looking for solutions to commercial and scientific challenges in:
● clinical trials
● antiviral therapies and much more.
We will identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis. Join us to learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.